Home/Filings/4/0001415889-25-000676
4//SEC Filing

Winter Charles M. 4

Accession 0001415889-25-000676

CIK 0001817713other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 8:10 PM ET

Size

7.7 KB

Accession

0001415889-25-000676

Insider Transaction Report

Form 4
Period: 2025-01-02
Winter Charles M.
Chief Technical Officer
Transactions
  • Award

    Common Stock

    2025-01-02+23,00077,288 total
  • Award

    Stock option (right to buy)

    2025-01-02+80,50080,500 total
    Exercise: $53.24Exp: 2035-01-01Common Stock (80,500 underlying)
Footnotes (3)
  • [F1]Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2026.
  • [F2]Includes 1,297 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan (the "Plan") on November 15, 2021, 1,644 shares acquired under the Plan on May 13, 2022, 2,401 shares acquired under the Plan on May 15, 2023, 2,834 shares acquired under the Plan on May 15, 2024 and 1 share acquired under the Plan on November 15, 2024.
  • [F3]25% of the shares subject to the option vest on January 1, 2026 and the balance will vest in equal monthly installments thereafter over a three year period.

Issuer

Janux Therapeutics, Inc.

CIK 0001817713

Entity typeother

Related Parties

1
  • filerCIK 0001960264

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 8:10 PM ET
Size
7.7 KB